MDT250110P76000
- 0.47
- 0.000.00%
Medtronic Newsroom
State-of-the-Art Intraoperative 3D Imaging Now Offered at Nicklaus Children's Hospital
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Medtronic Spinal Division Inks Agreement With Kuros Biosciences
Piper Sandler Maintains Medtronic(MDT.US) With Hold Rating
Hysteroscopy Instruments Market Research 2024-2028 & 2033 Featuring Major Players - Medtronic, Fujifilm, Stryker, Boston Scientific, and B. Braun Melsungen
Implantable Neurostimulation Devices Market Research 2024-2028 & 2033, Competitive Analysis of Major Players - Abbott Laboratories, Medtronic, Boston Scientific, Dignity Health, & St. Jude Medical
Is Medtronic's Dividend Safe?
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $97
RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
RBC Capital Sticks to Its Buy Rating for Medtronic (MDT)
Diabetes Device Maker Beta Bionics Files for $100M IPO
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Fire1 Raises $120M for Breakthrough Heart Failure Management Tech With Investment From Medtronic
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Endologix Announces Leadership Transition
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement With the Medtronic Spinal Division
Medtronic Chairman and CEO Geoff Martha to Speak at J.P. Morgan Healthcare Conference
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
Medtronic Receives CE Mark For Leading Transcatheter Pulmonary Valve Replacement System For Congenital Heart Disease